Fagan Associates, Inc. Edwards Lifesciences Corp Transaction History
Fagan Associates, Inc.
- $556 Million
- Q2 2024
A detailed history of Fagan Associates, Inc. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Fagan Associates, Inc. holds 4,472 shares of EW stock, worth $292,826. This represents 0.07% of its overall portfolio holdings.
Number of Shares
4,472
Previous 4,677
4.38%
Holding current value
$292,826
Previous $446,000
7.4%
% of portfolio
0.07%
Previous 0.08%
Shares
12 transactions
Others Institutions Holding EW
# of Institutions
1,417Shares Held
469MCall Options Held
2.44MPut Options Held
2.65M-
Vanguard Group Inc Valley Forge, PA53.6MShares$3.51 Billion0.1% of portfolio
-
Black Rock Inc. New York, NY51MShares$3.34 Billion0.11% of portfolio
-
State Street Corp Boston, MA26MShares$1.7 Billion0.11% of portfolio
-
Alliancebernstein L.P. New York, NY20.3MShares$1.33 Billion0.68% of portfolio
-
Wellington Management Group LLP Boston, MA16.9MShares$1.11 Billion0.29% of portfolio
About Edwards Lifesciences Corp
- Ticker EW
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 618,259,968
- Market Cap $40.5B
- Description
- Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...